Tom Mihaljevic, MD, is the incoming CEO and President of Cleveland Clinic. As of Jan. 1, 2018, he will lead the $8 million Cleveland Clinic health system, including a main campus, 10 regional hospitals, 18 family health centers, and facilities in Florida, Nevada, Toronto, Abu Dhabi and London.
Dr. Mihaljevic is currently CEO of Cleveland Clinic Abu Dhabi (CCAD). He oversaw the opening of the 365-bed hospital and clinic, with 3,000 caregivers, in 2015. Under his leadership, CCAD expanded its treatment capabilities, built relationships in the private and public sector, and established its growing reputation for clinical excellence, research and education.
From 2010 to 2015, Dr. Mihaljevic was Chief of Staff and Chairman of the Heart & Vascular Institute at CCAD. He led a recruitment effort that drew 5,500 applications for 175 physician posts, and went on to launch the most advanced cardiovascular program in the Middle East.
Dr. Mihaljevic joined Cleveland Clinic in 2004 as a surgeon in the Department of Thoracic and Cardiovascular Surgery. He has performed almost 3,000 operations over the course of his career, specializing in minimally invasive and robotic-assisted procedures, valve replacement and repair, image-guided surgery, heart failure and cardiac transplantation.
Dr. Mihaljevic received his medical degree from the Medical School, University of Zagreb, Croatia. He trained in cardiac surgery at the University of Zurich, Switzerland. In the United States, he did residencies in general and cardiothoracic surgery at Brigham and Women’s Hospital, and was chief resident in the Department of Cardiovascular Surgery at Boston Children’s Hospital.
Before coming to Cleveland Clinic, Dr. Mihaljevic was director of the Cardiac Surgery Research Laboratory and an associate surgeon in the Division of Cardiac Surgery at Brigham and Women’s Hospital in Boston. Dr. Mihaljevic held a seven-year academic appointment to Harvard Medical School as a Clinical Fellow in Surgery. He was also Assistant Professor of Surgery at Harvard Medical School.
Dr. Mihaljevic has been on the editorial review board for prestigious medical journals. He is the author or co-author of more than 130 articles in peer-reviewed publications, and is the author of textbook chapters on robotic and minimally invasive mitral valve surgery, and valvular heart disease. In 2005, Dr. Mihaljevic received a patent for a novel system for minimally invasive cardiac surgery.
His research has focused on minimally invasive cardiac surgery, robotic-assisted cardiac surgery, intracardiac imaging systems and analysis of beating heart intracardiac surgery, among other research studies. He has been an invited speaker at medical symposia and conferences worldwide.
Dr. Mihaljevic is a member of the American Association for Thoracic Surgery, American College of Cardiology, the American College of Chest Physicians, the American Heart Association, the Society of Thoracic Surgeons, the International Society of Heart and Lung Transplantation and the American Medical Association.
A native of Croatia and U.S. citizen, he speaks English, German and Croatian.